Related Experiment Video
Updated: Oct 26, 2025

10:37
Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
8.4K
Integrated Analysis of Multiple Microarray Studies to Identify Novel Gene Signatures in Ulcerative Colitis
Zi-An Chen1, Yu-Feng Sun1, Quan-Xu Wang1
1Department of Gastroenterology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Frontiers in Genetics
|July 26, 2021
Summary
This study identifies six key genes (LCN2, CXCL1, MMP3, IDO1, MMP1, S100A8) involved in ulcerative colitis (UC) pathogenesis. These genes are upregulated in UC patients and may play a role in immune response and cancer progression.
Area of Science:
- Genomics
- Molecular Biology
- Immunology
Background:
- Ulcerative colitis (UC) is a chronic inflammatory disease with rising global incidence.
- The precise molecular mechanisms driving UC pathogenesis remain incompletely understood.
Purpose of the Study:
- To identify key molecular players in ulcerative colitis (UC) pathogenesis.
- To elucidate the underlying molecular mechanisms of UC using bioinformatics and experimental validation.
Main Methods:
- Analysis of UC gene expression datasets from the GEO database.
- Robust Rank Aggregation (RRA) for identifying differentially expressed genes (DEGs).
- Protein-protein interaction (PPI) network analysis, MCODE, GO, KEGG, CytoHubba, and a DSS-induced mouse model for hub gene validation.
Main Results:
- Six public datasets were analyzed, revealing 208 significant DEGs (132 upregulated, 76 downregulated).
- Six hub genes (LCN2, CXCL1, MMP3, IDO1, MMP1, S100A8) were identified through integrated RRA and PPI network analysis.
- Enrichment analysis linked these genes to cytokine secretion, immune response, and cancer progression; mouse models confirmed higher expression in UC.
Conclusions:
- The identified hub genes are reliable indicators of UC molecular mechanisms.
- These findings enhance the understanding of UC pathogenesis and may offer therapeutic targets.

